Zoe Arvanitakis to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Zoe Arvanitakis has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.385
-
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008 May 06; 70(19 Pt 2):1795-802.
Score: 0.299
-
Clinical trial efforts in Alzheimer disease: why test statins? Neurology. 2010 Mar 23; 74(12):945-6.
Score: 0.087